Skip to main content

Unlocking the potential of AI in the pharma industry

While drug discovery was an early target for AI capabilities, the technology’s predictive powers have made it a good fit for many other facets of the industry. As pharma leverages real-world uses of AI, the industry has also been careful about big-picture hype for the technology as some of its limitations become clear.

included in this trendline
  • Ex-Novartis exec sets out to create ‘Apple of AI’
  • Can a top scientist and Moderna co-founder change the CRO game?
  • FDA inches closer to defining its regulatory role in AI
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.